Go to content
To the homepage of National Health Care Institute
National Health Care Institute
Home
Publications
Enter what you are looking for
Temsirolimus (Torisel) for the indication 'relapsed or refractory mantle cell lymphoma'
This report is a summary of recommendations by Zorginstituut Nederland. The original text is in Dutch.
Download:
Temsirolimus (Torisel) for the indication 'relapsed or refractory mantle cell lymphoma'
Report
25-08-2008
PDF document
48.59 KB